| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18831744 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 108 journal articles in the PubMed database | Email to a friend | | |
| Revicki DA, Menter A, Feldman S, et al.
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study. [JOURNAL ARTICLE]
Health Qual Life Outcomes 2008 Oct 2; 6(1):75.
Abstract | Full Citation | Find Related Articles | | Shikiar R, Heffernan M, Langley RG, et al.
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial. [Journal Article]
J Dermatolog Treat 2007; 18(1):25-31.
Abstract | Full Citation | Find Related Articles | | Revicki DA, Willian MK, Menter A, et al.
Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. [Journal Article]
J Dermatolog Treat 2007; 18(6):341-50.
Abstract | Full Citation | Find Related Articles | | Revicki D, Willian MK, Saurat JH, et al.
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. [JOURNAL ARTICLE]
Br J Dermatol 2007 Nov 28.
Abstract | Full Citation | Find Related Articles | | Revicki DA, Willian MK, Menter A, et al.
Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque Psoriasis. [JOURNAL ARTICLE]
Dermatology 2008 Jan 11; 216(3):260-270.
Abstract | Full Citation | Find Related Articles | | Loftus EV, Feagan BG, Colombel JF, et al.
Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial. [JOURNAL ARTICLE]
Am J Gastroenterol 2008 Oct 3.
Abstract | Full Citation | | Ortonne JP, Shear N, Shumack S, et al.
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
BMC Dermatol 2005.:13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Davis JC, Revicki D, van der Heijde DM, et al.
Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study. [Journal Article, Research Support, Non-U.S. Gov't]
Arthritis Rheum 2007 Aug 15; 57(6):1050-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gladman DD, Mease PJ, Cifaldi MA, et al.
Adalimumab improves joint- and skin-related functional impairment in patients with psoriatic arthritis: Patient- reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). [JOURNAL ARTICLE]
Ann Rheum Dis 2006 Oct 17.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
